Ascletis Pharma Inc.

Ascletis Accredited as “One of China’s Top Ten Innovative Companies in 2019”
2019-12-07
Ascletis successfully obtained Pharmaceutical Trade License and GSP Certificate, formed a Complete Commercial Layout
2019-11-29
Ascletis to Present at the 17th Annual Morgan Stanley Asia Pacific Summit
2019-11-26
Dr. Jinzi Wu was Selected as the 10th Science and Technology New Zhejiang Merchants
2019-11-08
Manuscript Publication of the First All-oral DAA HCV Regimen Developed by Ascletis from China in the Journal of Clinical and Translational Hepatology
2019-10-21
Ascletis Appoints Former Novartis Global Head Dr. Handan He as Chief Scientific Officer
2019-10-08
Dr. Jinzi J. Wu to Attend The Fortune Global Sustainability Forum 2019
2019-09-04
Ascletis Received IND Approval for its NASH Drug
2019-08-28
Ascletis Opens Clinical Development Shanghai Center
2019-08-12
Ascletis’ Strategic Partner 3-V Biosciences Announced its Name Change and Financing Status
2019-08-06

1

© 2018 Ascletis Pharma Inc. All Rights Reserved
浙公网安备 33010802003344号浙ICP备11050387号-1